4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
System Biosciences(授权代理)
主营:RNA干扰(RNAi)研究之相关工具
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > RNA_interference > SBI/Excision-only PiggyBac Transposase Expression Vector/10 µg/PB220PA-1-10 µg
商品详细SBI/Excision-only PiggyBac Transposase Expression Vector/10 µg/PB220PA-1-10 µg
SBI/Excision-only PiggyBac Transposase Expression Vector/10 µg/PB220PA-1-10 µg
SBI/Excision-only PiggyBac Transposase Expression Vector/10 µg/PB220PA-1-10 µg
商品编号: PB220PA-1-10µg
品牌: System Biosciences
市场价: ¥9040.00
美元价: 5424.00
产地: 美国(厂家直采)
公司:
产品分类: RNA干扰
公司分类: RNA_interference
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Overview

Reversible transgenesis that leaves no trace behind

One of the advantages of the PiggyBac Transposon System* is the reversibility of the integration event. With the Excision-only PiggyBac Transposase, delivered by transient transfection of the Exicison-only PiggyBac Transposase Expression Vector, you can remove any DNA integrated into the genome using the PiggyBac Transposon System. After removal of the PiggyBac insert, the genomic DNA is restored to the original sequence with no residual PiggyBac sequences left behind, resulting in a truly footprint-free removal.

Both the Excision-only PiggyBac Transposase and the Super PiggyBac Transposase (Cat.# PB210PA-1) recognize transposon-specific inverted terminal repeats (ITRs). While the Super PiggyBac Transposase has both excision and integration activities that enable the enzyme to mediate removal of the ITRs and intervening DNA from one location (the vector) and insert that DNA fragment into another location (the genome), the Excision-only PiggyBac Transposase only has the excision activity. Thus, the Excision-only PiggyBac Transposase can be used to remove DNA segments from the genome that are bordered by the PiggyBac transposon ITRs.

With the PiggyBac Transposon System, you can:

  • Make transgenic cell lines with a single transfection
  • Integrate multiple PiggyBac Vectors in a single transfection
  • Insert an expression cassette into human, mouse, and rat cells
  • Deliver virtually any-sized DNA insert, from 10 – 100 kb
  • Choose from PiggyBac Vectors that express your gene-of-interest from constitutive or inducible promoters and include a variety of markers
  • Determine the number of integration events with the PiggyBac qPCR Copy Number Kit (# PBC100A-1)

Customer AgreementsAcademic customers can purchase PiggyBac Transposon System components for internal research purposes for indefinite use, whereas commercial customers must sign a customer agreement for a four-month, limited-use license to evaluate the technology.For end user license information, see the following:

  • Academic Customers—End-User License Information
  • Commercial Customers—End-User License Information

* SBI is fully licensed to distribute PiggyBac vectors as a partnership with Hera BioLabs, Inc.

How It Works

The PiggyBac Transposon System’s Cut-and-Paste Mechanism

The efficient PiggyBac Transposon System uses a cut-and-paste mechanism to transfer DNA from the PiggyBac Vector into the genome. If only temporary genomic integration is desired, the Excision-only PiggyBac Transposase can be transiently expressed for footprint-free removal of the insert, resulting in reconstitution of the original genome sequence.

Figure 1. The PiggyBac Transposon System’s cut-and-paste mechanism.

  • The Super PiggyBac Transposase binds to specific inverted terminal repeats (ITRs) in the PiggyBac Cloning and Expression Vector and excises the ITRs and intervening DNA.
  • The Super PiggyBac Transposase inserts the ITR-Expression Cassette-ITR segment into the genome at TTAA sites.
  • The Excision-only Super PiggyBac Transposase can be used to remove the ITR-Expression Cassette-ITR segment from the genome, for footprint-free removal

Supporting Data

Reverse transgenesis with the PiggyBac Transposon System’s footprint-free excision process

Figure 2. SBI’s Excision-only PiggyBac Transposase is integrase-deficient but excision capable for reversible transgenesis. (Left panels) Comparison of the integration abilities of the Super PiggyBac Transposase (Cat.# PB210PA-1) to the Excision-only PiggyBac Transposase upon co-transfection with a GFP-expressing PiggyBac Vector. The very low number of GFP-positive cells in the sample co-transfected with Excision-only Transposase versus the numerous GFP-positive cells in the sample co-transfected with the Super PiggyBac Transposase demonstrate the poor integration abilities of the Excision-only enzyme. (Right panels) We inserted a GFP expression cassette into the genome, and then inactivated GFP expression by disrupting the open reading frame with a PiggyBac transposon. Successful use of the Excision-only PiggyBac Transposase restores GFP function, leading to GFP-positive cells. Restoration of GFP fluorescence also demonstrates the seamlessness of excision—the GFP coding region would remain disrupted if the transposon sequences did not get completely removed.

Resources

User Manual: PiggyBac Transposon System
Product Sheet: PiggyBac Transposon System
Brochure: Gene Delivery and Expression Products and Services

Citations

  • Schertzer, MD, et al. (2019) lncRNA-Induced Spread of Polycomb Controlled by Genome Architecture, RNA Abundance, and CpG Island DNA. Mol. Cell.2019 Jun 27;. PM ID:31256989
  • Denes, LT, et al. (2019) Culturing C2C12 myotubes on micromolded gelatin hydrogels accelerates myotube maturation. Skelet Muscle.2019 Jun 7; 9(1):17. PM ID:31174599
  • Richter, JF, et al. (2019) Occludin knockdown is not sufficient to induce transepithelial macromolecule passage. Tissue Barriers.2019 Jun 4; 7(2):1612661. PM ID:31161924
  • Mao, X, et al. (2019) Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000. Cancer Biol. Ther..2019 May 26;:1-12. PM ID:31131698
  • Chapnick, DA, et al. (2019) Temporal Metabolite, Ion, and Enzyme Activity Profiling Using Fluorescence Microscopy and Genetically Encoded Biosensors. Methods Mol. Biol..2019 May 24; 1978:343-353. PM ID:31119673
  • Shinmura, K, et al. (2019) POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma. Cancers (Basel).2019 May 24; 11(5). PM ID:31137743
  • Li, F, et al. (2019) A piggyBac-based TANGO GFP assay for high throughput screening of GPCR ligands in live cells. Cell Commun. Signal.2019 May 23; 17(1):49. PM ID:31122241
  • Shrestha, M, et al. (2019) The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation. Carcinogenesis.2019 May 10;. PM ID:31074490
  • Gan, L, et al. (2019) The lysosomal GPCR-like protein GPR137B regulates Rag and mTORC1 localization and activity. Nat. Cell Biol..2019 May 1; 21(5):614-626. PM ID:31036939
  • Ahmad, ST, et al. (2019) Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors. Nat Commun.2019 May 1; 10(1):2000. PM ID:31043608
  • Rivera, FJ, et al. (2019) Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination. Glia.2019 Apr 30;. PM ID:31038798
  • Inoue, M, et al. (2019) Structural Basis of Sarco/Endoplasmic Reticulum Ca2+-ATPase 2b Regulation via Transmembrane Helix Interplay. Cell Rep.2019 Apr 23; 27(4):1221-1230.e3. PM ID:31018135
  • Bielczyk-Maczyńska, E, et al. (2019) Loss of adipocyte identity through synergistic repression of PPARγ by TGF-β and mechanical stress. bioRxiv.2019 Apr 11;. Link:bioRxiv
  • Sakahara, M, et al. (2019) IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer. Cancer Sci..2019 Apr 1; 110(4):1293-1305. PM ID:30724425
  • Paydarnia, N, et al. (2019) Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells. Mol. Biol. Rep..2019 Apr 1;. PM ID:30937652
  • Jones, EM, et al. (2019) A Scalable, Multiplexed Assay for Decoding GPCR-Ligand Interactions with RNA Sequencing. Cell Syst.2019 Mar 27; 8(3):254-260.e6. PM ID:30904378
  • Sauter, EJ, et al. (2019) Induced Neurons for the Study of Neurodegenerative and Neurodevelopmental Disorders. Methods Mol. Biol..2019 Mar 23; 1942:101-121. PM ID:30900179
  • Laugsch, M, et al. (2019) Modeling the Pathological Long-Range Regulatory Effects of Human Structural Variation with Patient-Specific hiPSCs. Cell Stem Cell.2019 Mar 21;. PM ID:30982769
  • Farhadi, A, et al. (2019) Ultrasound Imaging of Gene Expression in Mammalian Cells. bioRxiv.2019 Mar 18;. Link:bioRxiv
  • Garivet, G, et al. (2019) Small-Molecule Inhibition of the UNC-Src Interaction Impairs Dynamic Src Localization in Cells. Cell Chem Biol.2019 Mar 13;. PM ID:30956149
Search all Citations
品牌介绍
美国SBI代理 System Biosciences,简称SBI,美国加州湾区新成立的生技公司,致力于独特、创新生物技术之开发,以研发利于基因及蛋白质功能鉴定、研究之崭新方法和工具为宗旨。 现阶段研发重心为RNA干扰(RNAi)研究之相关工具。 System Biosciences (SBI) 致力于开发独特、革新的技术,为客户研究蛋白组学和基因组学功能提供研究工具。SBI 是专业的慢病毒产品公司,提供基于慢病毒 美国SBI代理 ExoQuick and ExoQuick-TC Products Product Size Catalog # ExoQuick serum exosome precipitation solution (5 ml) 75 reactions EXOQ5A-1 ExoQuick Plasma prep and Exosome precipitation kit (5 ml ExoQuick plus 500 ul Thrombin at 500U/mL), replaces EXOQ5TD-1 product 75 reactions EXOQ5TM-1 Thrombin Plasma prep for Exosome precipitation (500 ul at 500U/mL), replaces TDEXO-1 product 100 reactions TMEXO-1 ExoQuick serum exosome precipitation solution (20 ml) 300 reactions EXOQ20A-1 ExoQuick-TC for Tissue Culture Media and Urine (10ml) 10 reactions EXOTC10A-1 ExoQuick-TC for Tissue Culture Media and Urine (50ml) 50 reactions EXOTC50A-1 Exosome-depleted FBS Media Supplement - USA Certified 50 ml EXO-FBS-50A-1 Exosome-depleted FBS Media Supplement - USA Certified 250 ml EXO-FBS-250A-1 ExoQuick-LP Lipoprotein Pre-Clear & Exosome Precipitation Kit 5 reactions EXOLP5A-1
联络我们
服务热线:4000-520-616
(限工作日9:00-18:00)
QQ :1570468124
手机:18915418616